Skip to Content
Morningstar

Medtronic PLC MDT

Morningstar Rating
Unlock
Stock XNYS Rating as of
$77.37 +0.25 (0.32%)
View Full Chart
As of Delayed Price Post-Trading: $77.52 +0.14
Unlock our analysis with Morningstar Investor
Start Free Trial

Company Report

View Archive

Though Underlying Business Remains Moaty, Potential for Expensive M&A Drives Moat Lower

Debbie Wang

Medtronic's standing as the largest pure-play medical-device maker remains a force to be reckoned with in the med-tech landscape. Pairing Medtronic's diversified product portfolio aimed at a wide range of chronic diseases with its expansive selection of products for acute care in hospitals has bolstered Medtronic's position as a key partner for its hospital customers.

Read Full Report

Price vs Fair Value

View History
MDT is trading at a 42% premium.
Price
$77.12
Fair Value
$884.00
Uncertainty
Medium
1-Star Price
$181.60
5-Star Price
$56.60
Economic Moat
Fpfdtzb
Capital Allocation
Yzwjnrqh

Bulls Say, Bears Say

Bulls

Medtronic has historically held roughly 50% share in its core heart devices. It's also the market leader in spinal products, insulin pumps, and neuromodulators for chronic pain.

Bears

As smaller firms introduce new insulin pump technology, Medtronic may face a stiffer fight to maintain its leadership in this arena.

Show More
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if MDT is a good fit for your portfolio.
Get 7 Days Free

News

View All

Trading Information

Previous Close Price
$77.12
Day Range
$76.52–77.50
52-Week Range
$68.84–91.00
Bid/Ask
$77.00 / $77.68
Market Cap
$99.21 Bil
Volume/Avg
7.1 Mil / 6.4 Mil

Key Statistics

Price/Earnings (Normalized)
14.80
Price/Sales
3.17
Dividend Yield (Trailing)
3.59%
Dividend Yield (Forward)
3.63%
Total Yield
5.47%

Company Profile

One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for roughly 50% of the company's total sales.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Large Value
Total Number of Employees
95,000
Website
https://www.medtronic.com

Competitors

Valuation

View More
Metric
MDT
JNJ
BSX
Price/Earnings (Normalized)
 14.8014.0035.71
Price/Book Value
 2.015.035.64
Price/Sales
 3.174.117.65
Price/Cash Flow
 14.1115.8332.46
Price/Earnings
MDT
JNJ
BSX

Financial Strength

Metric
MDT
JNJ
BSX
Quick Ratio
 1.310.840.94
Current Ratio
 2.031.171.66
Interest Coverage
 7.7323.578.88
Quick Ratio
MDT
JNJ
BSX

Profitability

Metric
MDT
JNJ
BSX
Return on Assets (Normalized)
 7.64%12.64%9.16%
Return on Equity (Normalized)
 13.51%31.72%16.77%
Return on Invested Capital (Normalized)
 9.78%20.11%11.67%
Return on Assets
MDT
JNJ
BSX
See how this stock stacks up to its competitors with Morningstar Investor
Start Free Trial

Medical Devices Industry Comparables

Screen With Investor
1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
ZdysbnlyCjqff$179.5 Bil
 Stryker Corp
SYK
FclyljcydRbg$128.2 Bil
 Boston Scientific Corp
BSX
JllvnkgkWcbwzm$112.3 Bil
 Edwards Lifesciences Corp
EW
MbpcngjxvhRnqggmz$54.4 Bil
 DexCom Inc
DXCM
PzcdflpvbtVwsnl$44.4 Bil
 Koninklijke Philips NV ADR
PHG
ZnvcmmmZksrhjd$23.6 Bil
 Zimmer Biomet Holdings Inc
ZBH
RvxtcwhxBdz$21.8 Bil
 Steris PLC
STE
NtybnwgdmWptdyk$21.6 Bil
 Align Technology Inc
ALGN
NjkqnlyfTtbptd$18.0 Bil

Sponsor Center